Short Interest in XOMA Co. (NASDAQ:XOMAP) Declines By 42.9%

XOMA Co. (NASDAQ:XOMAP) was the target of a large drop in short interest during the month of August. As of August 15th, there was short interest totaling 400 shares, adropof42.9% from the July 31st total of 700 shares. Based on an average daily trading volume, of 1,100 shares, the short-interest ratio is presently 0.4 days. Based on an average daily trading volume, of 1,100 shares, the short-interest ratio is presently 0.4 days.

XOMA Trading Up 0.4%

XOMA stock opened at $26.75 on Friday. XOMA has a fifty-two week low of $24.96 and a fifty-two week high of $27.20. The firm has a 50 day moving average price of $25.84 and a 200 day moving average price of $25.78.

XOMA Company Profile

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.